CSF2 and neoplasm: Consistently, PCI analysis found that G/D‐gETL NPs + HIPEC treatment led to the greatest tumor inhibition rate (85.1% reduced PCI of control), following with combination of GM‐CSF‐ or DTX‐loaded gETL NPs, or G/D‐ETL NPs, and HIPEC; while other treatment options resulted in significant less inhibition effect, and the inhibition rate in the G/D‐gETL NPs + HIPEC treatment group was 2.6 times greater that HIPEC alone (Figure 8e).